Answers are grounded in this paper and cite their sources.
Two glycosylated flavonoids, the quercetin-3- O -β- d -xylofuranosyl-(1 → 2)-α- l -rhamnopyranoside and myricetin-3- O -β- d -xylofuranosyl-(1 → 2)-α- l -rhamnopyranoside, were isolated from the CH 2 Cl 2 /MeOH fraction of Syzygium jambos (L.) Alston, Myrtaceae. The structures of these compounds were elucidated by spectroscopic means. The cytotoxicity of the compounds was evaluated against the RAW 264.7 cell lines by the lactate dehydrogenase assay. All analyzed compounds were less cytotoxic than the positive control (actinomycin D, CC 50 = 0.008 μM). The anti-inflammatory and anti-arthritic activities were evaluated by measuring inflammatory parameters in murine models. The two glycosylated flavonoids inhibited the production of tumor necrosis factor-α in RAW 264.7 cell line with IC 50 of 1.68 and 1.11 μM, respectively. In addition, all flavonoids decreased the levels of tumor necrosis factor-α, C-reactive protein, and fibrinogen at a dose of 5 mg/kg in murine models.
No takes yet. Share an insight, caveat, or question.
Ticona et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: